Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
next-generation Ebola vaccine
- Development stage
- Preclinical
- Lead developer
- Merck
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Next-generation Ebola vaccine candidates are being developed through a strategic collaboration between Sanofi and SK Bioscience. Currently in the preclinical stage, these vaccines are designed to induce protective immunity against the Ebola virus to prevent Ebola virus disease (EVD). The program leverages Sanofi's extensive global experience in vaccine development and SK Bioscience's research and manufacturing capabilities. While specific platform details—such as whether the candidates utilize viral vector, mRNA, or protein subunit technology—have not been publicly disclosed in primary pipeline listings, the initiative represents a collaborative effort to develop improved countermeasures against filovirus outbreaks with potentially enhanced stability or broader protection compared to first-generation vaccines.
- Other names
- next-gen Ebola vaccine candidatesSanofi/SK Bioscience Ebola vaccine
Beyond the preview
Go deeper on next-generation Ebola vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on next-generation Ebola vaccine.